Clinical Perspective
What Is New?
In a
longitudinal, population‐based sample of 13 168 residents from 4 US
communities followed for a median of 23.6 years, participants with
the metabolic syndrome had a 4.1% incidence of sudden cardiac death
compared with 2.3% among participants without it.
The metabolic
syndrome was independently associated with sudden cardiac death
irrespective of sex or race.
Sudden cardiac
death risk was proportional to the number of metabolic syndrome
components.
What Are the
Clinical Implications?
Sudden cardiac
death risk associated with the metabolic syndrome may be reduced by
treatment of high blood pressure, impaired glucose tolerance, and
lipid levels.
No comments:
Post a Comment